These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16039966)

  • 1. PPARgamma: a critical determinant of body fat distribution in humans and mice.
    Tsai YS; Maeda N
    Trends Cardiovasc Med; 2005 Apr; 15(3):81-5. PubMed ID: 16039966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARgamma coding region and its role in visceral obesity.
    Boon Yin K; Najimudin N; Muhammad TS
    Biochem Biophys Res Commun; 2008 Jun; 371(2):177-9. PubMed ID: 18413145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.
    Muise ES; Azzolina B; Kuo DW; El-Sherbeini M; Tan Y; Yuan X; Mu J; Thompson JR; Berger JP; Wong KK
    Mol Pharmacol; 2008 Aug; 74(2):403-12. PubMed ID: 18467542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
    Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma: the more the merrier?
    Argmann CA; Cock TA; Auwerx J
    Eur J Clin Invest; 2005 Feb; 35(2):82-92; discussion 80. PubMed ID: 15667578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat poetry: a kingdom for PPAR gamma.
    Anghel SI; Wahli W
    Cell Res; 2007 Jun; 17(6):486-511. PubMed ID: 17563755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
    Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.
    Carmona MC; Louche K; Lefebvre B; Pilon A; Hennuyer N; Audinot-Bouchez V; Fievet C; Torpier G; Formstecher P; Renard P; Lefebvre P; Dacquet C; Staels B; Casteilla L; Pénicaud L;
    Diabetes; 2007 Nov; 56(11):2797-808. PubMed ID: 17704298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The many faces of PPARgamma.
    Lehrke M; Lazar MA
    Cell; 2005 Dec; 123(6):993-9. PubMed ID: 16360030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
    Inoue M; Ohtake T; Motomura W; Takahashi N; Hosoki Y; Miyoshi S; Suzuki Y; Saito H; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2005 Oct; 336(1):215-22. PubMed ID: 16125673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity.
    Cheung KJ; Tzameli I; Pissios P; Rovira I; Gavrilova O; Ohtsubo T; Chen Z; Finkel T; Flier JS; Friedman JM
    Cell Metab; 2007 Feb; 5(2):115-28. PubMed ID: 17276354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
    Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
    Zieleniak A; Wójcik M; Woźniak LA
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.